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Abstract
Objective: The aim of this study was to assess re-hospitalization rates of individuals with psychosis 
and bipolar disorder and to study determinants of readmission. Methods: Prospective observational 
study, conducted in São Paulo, Brazil. One hundred-sixty-nine individuals with bipolar and psychotic 
disorder in need of hospitalization in the public mental health system were followed for 12 months 
after discharge. Their families were contacted by telephone and interviews were conducted at 1, 
2, 6 and 12 months post-discharge to evaluate readmission rates and factors related. Results: One-
year re-hospitalization rate was of 42.6%. Physical restraint during hospital stay was a risk factor 
(OR = 5.4-10.5) for readmission in most models. Not attending consultations after discharge was 
related to the 12-month point readmission (OR = 8.5, 95%CI 2.3-31.2) and to the survival model 
(OR = 3.2, 95%CI 1.5-7.2). Number of previous admissions was a risk factor for the survival model 
(OR = 6.6-11.9). Family’s agreement with permanent hospitalization of individuals with mental 
illness was the predictor associated to readmission in all models (OR = 3.5-10.9) and resulted 
in shorter survival time to readmission; those readmitted were stereotyped as dangerous and 
unhealthy. Conclusions: Family’s stigma towards mental illness might contribute to the increase in 
readmission rates of their relatives with psychiatric disorders. More studies should be conducted 
to depict mechanisms by which stigma increases re-hospitalization rates.
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Estigma e frequências mais altas de re-hospitalização psiquiátrica: o sistema público 
de saúde mental de São Paulo
Resumo
Objetivo: O objetivo desse estudo foi avaliar a frequência de re-hospitalizações de indivíduos 
portadores de psicose e transtorno bipolar, para estudar os determinantes da readmissão. Métodos: 
Estudo de observação prospectivo realizado em São Paulo, Brasil. Foram acompanhados 169 
portadores de psicose e de transtorno bipolar precisando de hospitalização no sistema público 
de saúde mental por 12 meses após a alta. Após contato por telefone com suas famílias, foram 
realizadas entrevistas a 1, 2, 6 e 12 meses após a alta para se avaliar a frequência de readmissões 
e os fatores relacionados às mesmas. Resultados: A frequência de re-hospitalizações após um ano 
foi de 42,6%. A contenção física durante a estadia hospitalar foi um fator de risco (RC = 5,4-10,5) 
de readmissão em muitos modelos. O não comparecimento às consultas após a alta foi relacionado 
à readmissão pontual aos 12 meses (RC = 8,5, IC 95% 2,3-31,2) e ao modelo de sobrevivência 
(RC = 3,2, IC 95% 1,5-7,2). O número de readmissões anteriores foi um fator de risco para o modelo 
de sobrevivência (RC = 6,6-11,9). A aprovação da família para a hospitalização permanente de 
indivíduos portadores de doença mental foi o fator de predição associado à readmissão em todos 
os modelos (RC = 3,5-10,9) e ocasionou tempos de sobrevivência mais curtos até a readmissão; 
aqueles readmitidos foram considerados de forma estereotipada como perigosos e não sadios. 
Conclusões: O estigma da família em relação à doença mental pode contribuir para o aumento 
na frequência de readmissões de seus familiares portadores de transtornos psiquiátricos. Outros 
estudos devem ser realizados para demonstrar os mecanismos pelos quais o estigma aumenta a 
frequência de re-hospitalizações. 
Introduction
In the past, psychiatric hospitalization was closely linked to 
stigma towards the mentally ill.1 People with mental disor-
ders were kept in hospitals, away from the community, for 
long periods and there was a stigmatizing belief that their 
treatment should be conducted in these facilities most of the 
time.2 However, in recent decades a great effort has been 
made to change such beliefs and practices.3-6
Firstly, the World Mental Health Organization stimulated 
the creation of public health policies worldwide to reduce 
psychiatric beds and substitute them with community treat-
ment facilities.7 From 1990 to 2002, the numbers of psychiat-
ric beds have decreased drastically in Europe. For instance, 
figures fell from 169 to 58 and from 132 to 63 psychiatric hos-
pital beds per 100,000 population in Sweden and in England, 
respectively.8 Secondly, deinstitutionalization movements 
have tried to return and reintegrate long-stay psychiatric 
inpatients to the community.9,10 Some studies demonstrated 
that this return to community had a positive effect on the 
clinical condition of the patients,11 whereas others showed 
that society’s stigmatization towards them increased.12 This 
contradicts the theory that contact with individuals with 
mental illnesses might reduce stigma against them.13 Finally, 
several anti-stigma campaigns have been launched to fight 
prejudice against the mentally ill.14,15
In order to solidly integrate these individuals into soci-
ety, however, the three factors mentioned above must act 
together. Otherwise stigma, an issue that has proven itself 
to be resilient within societies,16 can persist in diverse forms, 
also through psychiatric hospitalization. With the persistence 
of stigmatizing beliefs and given that current policies no 
longer allow lasting stays at psychiatric hospitals, this forced 
community contact with the mentally ill could elicit a “re-
volving door pattern”.17 Without a non-stigmatizing culture 
of deinstitutionalization firmly in place and an adequate 
community treatment services to shelter these individuals 
with mental illnesses, multiple brief hospitalizations would 
replace traditional long-term hospitalization.18 Thus, these 
heavy-users of psychiatric beds19 reflect resilient stigma and 
desire to maintain the mentally ill apart from society. 
According to this hypothesis, even though current psychi-
atric hospitalization criteria are mainly dictated by medical 
parameters, stigma could still have an enduring veiled effect 
on admission rates.20 Although numerous studies have focused 
on psychiatric re-hospitalization as a measure of relapse21 and 
many have used this issue to assess psychotropic effective-
ness,22,23 few have analyzed the influence of stigma at the 
time of re-hospitalization. 
The aim of this study was to assess re-hospitalization rates 
of individuals with psychosis and with bipolar disorder in the 
city of São Paulo, Brazil, and to study risk factors related to 
early readmission.
Methods
Background
The study was conducted in São Paulo, the largest metropolis 
of Brazil. The city has an estimated population of 11 mil-
lion inhabitants,24 and is the sixth most populous city in the 
world. A major mental health care reform has been carried 
out over the last 20 years in São Paulo:25,26 a national public 
health system was created, the Sistema Único de Saúde 
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(SUS); the number of psychiatric hospital beds has been 
drastically reduced; and many Centers for Psychosocial Care 
(Centro de Atenção Psicossocial – CAPS) – community outpa-
tients services – were created.26,27 CAPS are supposed to be 
intensive outpatient services, where individuals with greater 
need for assistance can attend the service more than once 
a week. Each CAPS has a multidisciplinary team consisting 
of psychiatrists, psychologists, nurses, social workers and 
occupational therapists. Aside from hospital beds and CAPS, 
there are the Basic Health Units (Unidade Básica de Saúde – 
UBS): community services, many of them with psychiatrists, 
where patients are seen on a monthly basis. At the time of 
the study, there were 5 stand-alone psychiatric hospitals, 10 
general hospitals with psychiatric beds, 43 CAPS and 546 UBS 
operating in the city.28 Studies published a few years before 
this present study showed that mental health care resource 
figures were similar to other developed countries: in 2005, 
São Paulo had 13.2 psychiatric beds per 100,000 population, a 
number comparable to countries where deinstitutionalization 
has been longstanding, and 6.13 psychiatrists per 100,000 
population, which was similar to figures of high-income 
countries as well.7,28 According to Saxena et al.,29 Brazil 
has a good number of human resources for mental health 
care per capita, as represented by São Paulo, the country’s 
richest city.
The statistics mentioned above reflect the public mental 
health care system. In parallel, there is a private mental 
health care system – called supplementary health system – 
which will not be considered in the present study because, 
first, data on this system is scarce if not absent; second, 
the great majority of the population uses the public health 
system.
Sampling and procedure
The subjects for this study were recruited from the Hospital 
Psiquiátrico Philippe Pinel, one of five public stand-alone 
psychiatric hospitals of São Paulo. This facility has 36 acute 
psychiatric beds for males and 12 for females, being respon-
sible for almost 10% of the hospitalizations of individuals 
with psychosis and bipolar disorder (ICD-10 F2 and F31/F30) 
of the metropolis.30 
Patients are only admitted to the facility through emer-
gency units located throughout the city. Individuals are 
referred from these units to the hospital on an as-needed 
basis; thus, inpatients originate from all regions of the met-
ropolitan area. Also, specifically at this hospital, all psychiatric 
diagnoses are accepted for hospitalization; the only exception 
being subjects with substance use disorder as the primary 
diagnosis. These individuals are admitted elsewhere. Hence, 
individuals at this hospital are considered representative 
of the city’s bipolar and psychotic disorder patients who 
required hospitalization in the public health system.
The study sample comprised adult subjects consecutively 
discharged from the hospital from May to August 2009. During 
each month of the study, patients and their families were 
consecutively asked at the time of their discharge whether 
they were willing to participate in the study. After provid-
ing a description of the study to the participants, a written, 
informed consent was obtained. If a number between 40 and 
50 participants was reached for the month, the recruiting was 
suspended and reinitiated at the beginning of the following 
month. After discharge, an appointment was made at the 
CAPS nearest to the patient’s home. As a rule, this took 
place no more than one month after they left the hospital.
Of the total discharges in this four-month period 
(n = 271), 216 (79.7%) were randomly invited to participate 
in the study. Of these, 176 (81.5%) agreed to collaborate, 
signed an informed consent form and would be contacted at 
least once after discharge.
The sample had an array of different diagnoses. In order 
to obtain a more homogenous sample, only individuals with 
the diagnosis of psychosis or bipolar disorder (ICD-10 F2 
or F31/F30) were considered for analysis; individuals with 
substance abuse disorder (n = 1, 0.6%), unipolar depression 
(n = 2, 1.1%), mental retardation (n = 1, 0.6%) and organic 
mental disorder (n = 3, 1.7%) as the primary diagnosis were 
not considered. This resulted in a final sample of 169 
individuals. 
Next, a social worker contacted the patient’s family by 
telephone at four different points in time: 1 month, 2 months, 
6 months and 12 months after discharge from the index hos-
pitalization. The social worker tried to reach every family 
at the specific time points several times. If contact was not 
made in the month designated for the team to call the family, 
it was considered a refusal. From the 169 families, 145 (86%) 
were contacted in the first month, 136 (81%) in the second 
month, 134 (79%) at month 6 and 108 (64%) at month 12.
Instrument and measures
The instrument was a specific questionnaire designed for the 
study. The first part was filled out by the main investigator 
with data from the patient’s hospital file. Sociodemographic 
data, data on the psychiatric disorder, information about 
the hospital stay and the hospital discharge were collected. 
The second part was filled out by the social worker by 
telephone interviews. It consisted of 6 parts; 1) individual’s 
general behavior; 2) attendance to his/her outpatient con-
sultations, and if not, why; 3) medication compliance; 4) 
in this part the interviewer asked whether the subject was 
re-hospitalized since index hospitalization (re-hospitalization 
was also considered if the patient was readmitted elsewhere 
than the hospital where the study was conducted), including 
reason why the individual was re-hospitalized; 5) informa-
tion about drug use; 6) questions about the family’s opinion 
on psychiatric hospitalization (“Do you agree with brief 
hospitalization?”; “Do you wish your relative had stayed a 
longer time at the hospital?”; “Do you agree with permanent 
hospitalization of the mentally ill?”).
For the last phone interview (12 months post-discharge), 
a stereotype questionnaire used in previous studies was 
filled out.31 The family member was asked to compare his 
relative to someone in the general population, regarding 12 
stereotypes: dangerous, creative, unpredictable, healthy 
(body and soul), less intelligent, bedraggled, controlled, 
abnormal, gifted, unreliable, reasonable, weird. Possible 
answers to the questions on stereotypes were: “more pres-
ent”, “equally present”, or “less present”.
As outcome variables, point-estimates of re-hospital-
ization in the interview schedule (1 month, 2 months, 6 
months and 12 months) were used. That is, for these outcome 
variables, only data obtained at those specific time-points 
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were considered. A further variable was created representing 
the survival to re-admission (“re-hospitalization survival”), 
considering data obtained from all time-points.
We used the following 15 predictors: age (years, continu-
ous), sex (male vs. female), number of previous hospitalizations 
(none; 1; 2 to 5; 6 to 10; 11 or more), not taking medication 
before admission (yes vs. no), duration of hospitalization (con-
tinuous, days), physically restrained during hospital stay (yes vs. 
no), anti-psychotic dose on discharge (continuous, calculated 
on chlorpromazine-equivalents), type of anti-psychotics on 
discharge (typical; atypical; atypical plus typical), depot anti-
psychotics on discharge (yes vs. no), number of antipsychotics 
on discharge (continuous), number of psychotropics on discharge 
(continuous), attending outpatient consultations after discharge 
(yes vs. no), taking medication after discharge (yes vs. no), 
family’s agreement with permanent hospitalization (yes vs. 
no), family’s agreement with brief hospitalization (yes vs. no).
Outcome variables did not show statistically significant 
differences between individuals with psychosis and individu-
als with bipolar disorder; therefore, the sample was analyzed 
as a whole as opposed to being split up according to diagnosis. 
Statistical analysis
Participants and non-participants were compared. An inde-
pendent t-test was conducted for the continuous variables 
(age and duration of hospital stay); and for categorical 
variables (sex, diagnosis of entry and of discharge, number 
of previous hospitalizations and time since the illness began) 
Chi-square tests were used.
Backwards stepwise logistic regression was conducted be-
tween the predictors and outcome variables. Other variables 
differing from those described in the previous subsection 
as “predictors” (family member visits during hospital stay, 
reason of admission and family’s desire for a longer hospital 
stay) were excluded since exploratory analysis conducted by 
calculating chi-square coefficients between them revealed 
no association with the outcome.
Afterwards, a Cox proportional hazards regression model 
was used to obtain the best predictor for time to one-year 
re-hospitalization. Variables that yielded significant cor-
relations in the logistic regression were entered. Next, this 
predictor was used to conduct two distinct Kaplan-Meyer 
survival curves, considering “re-hospitalization survival” as 
the outcome. Log rank was used to estimate statistical dif-
ference between the two curves.
Since stereotype information was obtained only in the 
last round of interviews, at 12 months after discharge this 
information was not included in the previous analyses in order 
to not reduce the sample for the regression. Only 108 fami-
lies could be contacted at this final time-point. Stereotypes 
were thus compared between those re-admitted and those 
not re-admitted by means of chi-square analysis.
All statistical analyses were conducted with SPSS 18.0 
(PASW) for Windows. Two-tailed tests and level of significance 
(p) of 0.05 were used.
Results
Analyzing participants and non-participants, no statistical 
differences were found between them regarding mean age, 
sex, diagnosis of entry and of discharge, mean duration of 
hospital stay, number of previous hospitalizations and time 
since the illness began (data not shown). The majority of par-
ticipants were single males, with their last admission within 
one year before study entry (64.6%). Sample characteristics 
are shown in Table 1. Of the 169 individuals of the study, 72 
(42.6%) were readmitted at least once within 12 months of 
their hospital discharge date.
At the 1-month post-discharge time-point, not taking 
medication before the hospitalization was protective (OR = 0.2, 
0.1-0.7 95%CI) and physical restraint during admission was a risk 
factor (OR = 7.4, 1.9-28.4 95%CI). At the 2-month time-point, 
again, not taking medication before the hospitalization was 
protective (OR = 0.3, 0.1-0.8 95%CI) and physical restraint during 
admission was a risk factor (OR = 5.4, 1.5-19.2 95%CI). Depot 
antipsychotics at discharge were also a risk factor (OR = 6.0, 
95%CI 1.7-21.8). At the 12-month time-point not taking medica-
tion before the hospitalization was protective (OR = 0.3, 0.1-0.9 
95%CI) and physical restraint during hospital stay was a risk 
factor (OR = 10.5, 2.2-50.8 95%CI). Having 11 or more previous 
admissions was a risk factor for individuals contacted at this 
time (OR = 8.8, 95%CI 1.1-68.6), as well as not going to outpa-
tient consultations after discharge (OR = 8.5, 95%CI 2.3-31.2). 
Summing data from all time points in the “re-hospitalization 
survival” model, a higher number of previous admissions 
Table 1 Sample characteristics (n = 169)
Age (years; mean, range) 37.5 (18-65)
Male gender (%,n) 79.3% (134)
Between 1 and 8 years of study (%,n) 86.4% (146)
Single (%,n) 85.8% (145)
Duration of hospital stay (days; mean, range) 17.3 (1-44)
First hospitalization (%,n) 7.7% (13)
Number of previous hospitalizations (%,n)
11 or more: 24.3% (41)
6 to 10: 13% (22)
2 to 5: 35.5% (60) 
1: 11.8% (20)
When was the last admission? (%,n)
Less than 1 year: 64.6% (93)
1 to 2 years: 21.5% (31)
Not taking medication at time of admission 53.3% (90)
Physical restraint during hospitalization 18.3% (31)
Medication at discharge
Only typical 69.8% (118)
Only atypical 5.9% (10)
Typical and atypical 18.3% (31)
No antipsychotics 5.9% (10)
Depot antipsychotics 17.2% (27)
Diagnosis at discharge
Psychotic disorder 111 (65.7%)
Bipolar Disorder 43 (25.4%)
Schizoaffective disorder 9 (5.3%)
Unspecified psychosis 6 (3.6%)
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(OR = 6.6 to 11.9) and not attending outpatient consultations 
(OR = 3.2, 95%CI 1.5-7.2) were also risk factors. What was consis-
tent among all models was family’s agreement with permanent 
hospitalization of the mentally ill being a risk factor (OR ranging 
from 3.5 to 10.9). Other variables, such as age, sex, duration 
of hospital stay, antipsychotics dose, type of antipsychotics and 
number of psychotropics at discharge, as well as taking medica-
tions after discharge, did not show a significant correlation to 
readmission in any of the models (Table 2).
All the above-mentioned variables were used in the Cox 
proportional hazards regression model, which after 8 steps 
indicated “family’s agreement with permanent hospitaliza-
tion of the mentally ill” as the best predictor for time to 
one-year re-hospitalization (OR = 2.24, 95%CI 1.34-3.75). 
Thus, Kaplan-Meier survival analysis showed that individuals 
whose family agreed with permanent hospitalization had a 
significantly worse outcome with a shorter time to re-hos-
pitalization (mean survival time = 10.44 vs. 11.00 months; 
chi2 = 13.65, p < 0.001) (Figure 1). Individuals readmitted 
were significantly more stereotyped as dangerous (chi2 = 9.76, 
p < 0.01) and ill (chi2 = 12.01, p < 0.01) (Figure 2).
Table 2 Logistic regression of re-hospitalization at different time-points and re-hospitalization survival
1 month
(n = 145)
2 months
(n = 136)
6 months
(n = 134)
12  months
(n = 108)
Re-hospitalization 
suvival (n = 169)
OR
(95%CI)
OR
(95%CI)
OR
(95%CI)
OR
(95%CI)
OR
(95%CI)
Higher age * * 0.9
(0.9-1.0)
* 1.0
(0.9-1.0)
Number of previous hospitalizations
        0 * * * 1 1
        1 0.5
(0.0-9.7)
2.4
(0.3-17.5)
        2 to 5 3.5
(0.5-26.1)
6.6
(1.2-37.1)
        6 to 10 6.0
(0.6-56.6)
10.8
(1.6-75.2)
        11 or more 8.8
(1.1-68.6)
11.9
(1.9-74.7)
Not taking medication before hospitalization 0.2 
(0.1-0.7)
0.3 
(0.1-0.8)
* 0.3
(0.1-0.9)
0.5
(0.2-1.0)
Physical restraint during hospital stay 7.4
 (1.9-28.4)
5.4 
(1.5-19.2)
* 10.5
(2.2-50.8)
*
Longer hospitalization 0.9 
(0.9-1.0)
* * * *
Number of psychotropics on discharge * 0.7 
(0.4-1.0)
* * *
Depot antipsychotic on discharge * 6.0 
(1.7-21.8)
* * *
Not attending to consultations after discharge * * * 8.5
(2.3-31.2)
3.2
(1.5-7.2)
Agreement with permanent hospitalization 5.0 
(1.7-14.7)
3.8 
(1.3-10.7)
4.1 
(1.6-10.6)
10.9
(3.1-37.9)
3.5
(1.6-7.6)
* Variable not present in the final model.
Figure 1 Kaplan-Meier Survival functions according to 
family’s agreement with permanent hospitalization.
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When asked what could have possibly prevented the 
re-hospitalization, families were unanimous in choosing the 
option that “the patient should have stayed longer in the 
hospital before leaving it”. No family stated insufficiency of 
outpatient services as the cause of re-admittance.
Discussion
This is one of the few studies to analyze re-hospitalization 
rates in a Latin American country where psychiatric beds have 
been drastically reduced.32 Our results showed that in such 
settings stigma might play an important role in influencing 
readmission.
Similar to what is usually stated in the literature,33,34 
after one year the re-hospitalization rate for individuals of 
the sample was of 42.6%. Not taking medication before index 
hospitalization was protective, whereas physical restraint 
during hospitalization was a risk factor for readmission in 
most models. Depot antypsichotics on discharge was a risk 
factor for the 2-month assessment point, while greater 
number of previous admissions and not attending consulta-
tions after discharge were factors related to the 12-month 
assessment and to the survival model. Family’s agreement 
with permanent hospitalization of the individual with mental 
illness was the variable associated with readmission in all 
models, being the best predictor for readmission and result-
ing in a shorter survival time to rehospitalization. Also, those 
readmitted were stereotyped as dangerous and unhealthy. 
Families complained about the short duration of hospitaliza-
tion as the main cause for rehospitalization.
Our results suggest that risk to readmission may depend 
mainly on three factors: adherence, severity of illness and 
stigma.
The main reason for admission for patients reporting 
that they were “not taking medication at time of admission” 
probably was their non-compliance to medical treatment.35-37 
For adherent patients who reported they were taking their 
medication, stigma or refractoriness might have been the 
cause of admission instead. For patients reporting not taking 
medication before hospital entrance, the admission itself and 
the restored adherence during their hospital stay protected 
them against future hospitalizations and thus non-adherence 
turned into a protective factor (for the other patients, ad-
mission did not interfere with stigma and refractoriness). 
Along the same lines, in clinical practice depot-medication 
is usually administered for those who are non-adherent.38,39 
At the 2-month post-discharge period, haloperidol-decanoate 
(the only depot antipsychotic available in the public health 
system) administered just before departure would no longer 
produce an effect; consequently, non-adherent individuals 
discharged on this medication became more prone to rehos-
pitalization at this period. Another proxy to non-adherence 
acting as a risk factor, for instance, would be not attending 
outpatient treatment after leaving the hospital.
As for the second factor, when considering medication 
quantity as a proxy for illness severity, variables related to 
this issue did not show a correlation. With the exception of 
the above-cited depot-antipsychotic, the type of antipsychot-
ics again did not predict earlier re-hospitalization, similarly 
to what was suggested by Kennedy and colleagues.40 However, 
the need for physical restraint during hospitalization could 
indicate a more aggressive behavior, being a consequence of 
a more severe disorder or even a non-compliance character-
istic of the individual.37 As in our findings, other studies have 
shown that the number of previous hospitalizations was the 
strongest predictor for rehospitalization;41 this fact could 
also be interpreted in part as a proxy for disorder severity. 
These first two factors are well described in the litera-
ture. What our study brings to light, though, is the third 
factor mentioned: stigma and readmission. The family’s 
agreement with permanent hospitalization of the psychiat-
ric patient was the best predictor of readmission and could 
be interpreted as a reiterated wish to institutionalize their 
relative with mental illness, to keep them away from the 
family. The number of previous hospitalizations as a risk fac-
tor could also be seen as a reflection or consequence of this 
desire. A hypothesis linking the three factors would be that 
stigma could possibly result in a vicious cycle: more family 
stigma leads to neglect of the relative’s treatment, which in 
turn could lead to worse symptom control, leading to more 
stigma and recurrent hospitalizations. This could worsen the 
outcome, make the disorder chronic, and, finally, consolidate 
stigma. Also, if long-term hospitalization is no longer possible 
today due to worldwide mental health care reform, which 
has also reached Brazil,42 such a desire to segregate the in-
dividual with mental illness from society could probably be 
camouflaged into multiple brief hospitalizations. This is also 
reinforced by the fact that those with family stigma had a 
significantly shorter survival to readmission. 
Although several studies have assessed stigma towards 
mental illness in São Paulo and Brazil in general,43-45 none 
have linked stigma to their practical consequence, such as 
higher readmission rates. Accordingly, literature states that 
stigma comprises three different but correlated aspects: 
stereotyping, prejudice and social distance.46 Stereotypes 
are knowledge structures designed to categorize people in 
order to deal with them. Re-hospitalized individuals were 
repeatedly stereotyped as dangerous and unhealthy. Their 
families more often reported beliefs that people with mental 
illness should be permanently hospitalized (prejudice) and, 
therefore possibly brought these patients more often for 
psychiatric hospital admission (social distance). 
Finally, what might also be seen somewhat as a sign of 
stigmatization of individuals with mental illness is that all 
families stated a short duration of hospitalization as the 
Figure 2 Stereotypes attributed to patients compared to 
someone of the general population, considering survival to 
re-admission after 12 months.
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major cause of re-hospitalization instead of an insufficiency 
of outpatient services. This reveals the hospital-based 
treatment beliefs of these families, despite all efforts to 
maintain the individual with psychiatric disorders integrated 
into the community.
One limitation of the study is that side-effects were not 
addressed after discharge. As the majority of the sample 
was under the effect of typical anti-psychotics, side-effects 
related to them could be an issue influencing adherence 
and relapse, for example. However, type of anti-psychotics 
was not significantly related to compliance issues, and were 
excluded from final regression models. Another debatable 
point is that, although the study is representative of bipolar 
and psychotic patients of the public mental health system, 
no data on the private system is available. Thus, it would 
be of interest to know whether the findings are different 
for those using the private health system for psychiatric 
issues. One could argue that another limitation is that no 
structured instrument evaluating illness severity could be 
applied before the patients left the hospital, since this was 
an observational study. However, we chose to use several 
variables such as physical restraint and medication issues 
as proxy to case severity.
Conclusion
The present study replicates findings of the literature report-
ing that factors such as adherence and severity of illness 
might influence readmission rates. However, stigma was also 
observed as an important factor contributing to the risk of 
re-hospitalization. A family’s wish to keep individuals with 
mental illness permanently hospitalized might contribute to 
the “revolving door” readmission pattern of their relatives 
with psychiatric disorders.
Therefore, in order to more precisely depict the nature 
of this correlation between stigma and readmission rates, 
more studies in the field should be conducted. Also other 
services and regions of the country should be involved, so as 
to assess whether this is related to the psychiatric culture of 
the Brazilian population, or with mental health care reform, 
for example. Those families whose relatives have recurrent 
hospitalizations should be especially addressed regarding, 
for instance, stigma and beliefs about psychiatric illness and 
psychiatric treatment.
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